2026-IdrDip-06-medmol - Germline predisposition to the onset of Ph-negative myeloproliferative neopl
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
Organisation/Company Università di Pavia Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 25 Nov 2026 - 12:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Offer Description
The projects has 3 main aims: 1)To evaluate the prevalence of germline mutations in DNA repair genes in MPN and their correlation with the clinical phenotype; 2) to explore in hematopoietic stem and progenitor cells how germline CHEK2 variants synergize with the classical MPN driver mutations in JAK2 to promote clonal expansion and disease manifestation; 3) to test whether familial surveillance is able to preemptively identify solid cancers and myeloid disorders in presymptomatic relatives carrying mutations in DNA repair genes.
The public call with detailed attendance and selection rules (Art 4 and 6) can be found at:
The selections are open to candidates, Italian or foreigner, in possession, on the date of the deadline for submitting applications for the admission to the selection, of a master's degree or single-cycle, degree obtained no more than six years previously are eligible to participate in the selection process. These degrees must be relevant to the subject of the research activity.
Further specific assessable qualifications (see Art. 1 par. 1 Call for applications):
Specialization in Hematology
Experience in clinical and translational research
Experience in the methodology of planning and conducting clinical and translational studies;
Proficiency in spoken and written English
AFRICA
EUROPE
OCEANIA
NORTH AMERICA
SOUTH AMERICA
ASIA
OTHER
Eligibility of fellows: country/ies of residence:
AFRICA
EUROPE
OCEANIA
NORTH AMERICA
SOUTH AMERICA
ASIA
OTHER
Eligibility of fellows: nationality/ies:
AFRICA
EUROPE
OCEANIA
NORTH AMERICA
SOUTH AMERICA
ASIA
OTHER
Selection process
The application for admission to the selection procedure (dated and signed),the documents and publications considered useful for the evaluation must be submitted, under penalty of exclusion, electronically, by visiting the following web page: selecting the Competition Notice you have chosen. In order to register with the system, you must have an email address. Following the guidelines published in the procedure, the applicant must enter all the information required for the application, enclosing all documents in electronic .PDF format. The selection of candidates is carried out on the basis of qualifications and possible interview (with test of knowledge of the foreign language) (see Art. 1 par. 1 Call for applications).